FDA — authorised 25 July 1996
- Application: NDA020625
- Marketing authorisation holder: CHATTEM SANOFI
- Local brand name: ALLEGRA
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Allegra in United States
FDA authorised Allegra on 25 July 1996
Marketing authorisations
FDA — authorised 24 December 1997
- Application: NDA020786
- Marketing authorisation holder: CHATTEM SANOFI
- Status: approved
FDA — authorised 25 February 2000
- Application: NDA020872
- Marketing authorisation holder: CHATTEM SANOFI
- Status: supplemented
FDA — authorised 19 October 2004
- Application: NDA021704
- Marketing authorisation holder: CHATTEM SANOFI
- Status: supplemented
FDA — authorised 16 October 2006
- Application: NDA021963
- Marketing authorisation holder: CHATTEM SANOFI
- Local brand name: ALLEGRA
- Indication: SUSPENSION — ORAL
- Status: approved
FDA — authorised 26 July 2007
- Application: NDA021909
- Marketing authorisation holder: CHATTEM SANOFI
- Status: supplemented
FDA — authorised 24 January 2011
- Application: NDA201373
- Marketing authorisation holder: CHATTEM SANOFI
- Status: approved
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Allegra approved in United States?
Yes. FDA authorised it on 25 July 1996; FDA authorised it on 24 December 1997; FDA authorised it on 25 February 2000.
Who is the marketing authorisation holder for Allegra in United States?
CHATTEM SANOFI holds the US marketing authorisation.